The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
American Gastroenterological Association Technical Review on the Management of Barrett's Esophagus
Open accessAbstract
The aim of evidence-based medicine is to improve the quality of health care by integrating the best research evidence with clinical expertise and patient values. Evidence-based clinical guidelines are sets of recommendations intended to assist health care providers and patients in selecting the best management for common clinical situations while accounting for patient-specific circumstances. In addition to providing optimal, patient-centered care and improved outcomes, guidelines can reduce practice variability, identify gaps in evidence, enhance efficiency of resource use, and facilitate development of outcome and performance measures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Hospital Volume and Surgical Mortality in the United States
Birkmeyer, J. D., Siewers, A. E., Finlayson, E. V. A., Stukel, T. A., Lucas, F. L., Batista, I., Welch, H. G., & Wennberg, D. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa012337 · Cited by 4,999
Vakil, N., van Zanten, S. V., Kahrilas, P., Dent, J., Jones, R., & the Global Consensus Group (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00630.x · Cited by 3,924
Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma
Lagergren, J., Bergström, R., Lindgren, A., & Nyrén, O. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903183401101 · Cited by 3,020
Locke, G., Talley, N., Fett, S., Zinsmeister, A., & Melton, L. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70025-8 · Cited by 2,095
Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus
Wang, K. K., & Sampliner, R. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01835.x · Cited by 2,014
Impact of Hospital Volume on Operative Mortality for Major Cancer Surgery
Begg, C. B. (1998) · JAMA · doi:10.1001/jama.280.20.1747 · Cited by 1,657
Radiofrequency Ablation in Barrett's Esophagus with Dysplasia
Shaheen, N. J., Sharma, P., Overholt, B. F., Wolfsen, H. C., Sampliner, R. E., Wang, K. K., Galanko, J. A., Bronner, M. P., Goldblum, J. R., Bennett, A. E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808145 · Cited by 1,438
Self-citation
Research works printed but not linked: 161
- Sharma, 2004, A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop, Gastroenterology, 127, 310, 10.1053/j.gastro.2004.04.010 · doi:10.1053/j.gastro.2004.04.010
- McClave, 1987, Early diagnosis of columnar-lined esophagus: a new endoscopic criterion, Gastrointest Endosc, 33, 413, 10.1016/S0016-5107(87)71676-9 · doi:10.1016/s0016-5107(87)71676-9
- Choi do, 2002, Endoscopically observed lower esophageal capillary patterns, Korean J Intern Med, 17, 245, 10.3904/kjim.2002.17.4.245 · doi:10.3904/kjim.2002.17.4.245
- Vianna, 1987, Normal venous circulation of the gastroesophageal junction, Gastroenterology, 93, 876, 10.1016/0016-5085(87)90453-7 · doi:10.1016/0016-5085(87)90453-7
- Spechler, 2004, Intestinal metaplasia at the gastroesophageal junction, Gastroenterology, 126, 567, 10.1053/j.gastro.2003.11.061 · doi:10.1053/j.gastro.2003.11.061
- Chandrasoma, 1997, Pathophysiology of Barrett's esophagus, Semin Thorac Cardiovasc Surg, 9, 270
- Sharma, 1998, Short segment Barrett's esophagus, Am J Gastroenterol, 93, 1033, 10.1111/j.1572-0241.1998.00324.x · doi:10.1111/j.1572-0241.1998.00324.x · Paper page
- Aldulaimi, 2005, Barrett's surveillance is worthwhile and detects curable cancers, Eur J Gastroenterol Hepatol, 17, 943, 10.1097/00042737-200509000-00010 · doi:10.1097/00042737-200509000-00010
- Chang, 2007, The effect of antireflux surgery on esophageal carcinogenesis in patients with Barrett esophagus: a systematic review, Ann Surg, 246, 11, 10.1097/01.sla.0000261459.10565.e9 · doi:10.1097/01.sla.0000261459.10565.e9
- Thomas, 2007, Meta analysis: cancer risk in Barrett's oesophagus, Aliment Pharmacol Ther, 26, 1465, 10.1111/j.1365-2036.2007.03528.x · doi:10.1111/j.1365-2036.2007.03528.x
- Alcedo, 2009, Trends in Barrett's esophagus diagnosis in Southern Europe: implications for surveillance, Dis Esophagus, 22, 239, 10.1111/j.1442-2050.2008.00908.x · doi:10.1111/j.1442-2050.2008.00908.x
- Anderson, 2003, Mortality in Barrett's oesophagus: results from a population based study, Gut, 52, 1081, 10.1136/gut.52.8.1081 · doi:10.1136/gut.52.8.1081
- Eckardt, 2001, Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation, Am J Med, 111, 33, 10.1016/S0002-9343(01)00745-8 · doi:10.1016/s0002-9343(01)00745-8
- Moayyedi, 2008, Mortality rates in patients with Barrett's oesophagus, Aliment Pharmacol Ther, 27, 316, 10.1111/j.1365-2036.2007.03582.x · doi:10.1111/j.1365-2036.2007.03582.x
- Solaymani-Dodaran, 2005, Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses-a population-based cohort study, Am J Gastroenterol, 100, 2616, 10.1111/j.1572-0241.2005.00340.x · doi:10.1111/j.1572-0241.2005.00340.x
- Rana, 2000, Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance, Dis Esophagus, 13, 28, 10.1046/j.1442-2050.2000.00069.x · doi:10.1046/j.1442-2050.2000.00069.x
- Van der Burgh, 1996, Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus, Gut, 39, 5, 10.1136/gut.39.1.5 · doi:10.1136/gut.39.1.5
- Wiklund, 1998, Quality of Life in Reflux and Dyspepsia patients, Eur J Surg Suppl, 41
- Shaheen, 2005, Effect of a new diagnosis of Barrett's esophagus on insurance status, Am J Gastroenterol, 100, 577, 10.1111/j.1572-0241.2005.41422.x · doi:10.1111/j.1572-0241.2005.41422.x
- Abrams, 2008, Racial and ethnic disparities in the prevalence of Barrett's esophagus among patients who undergo upper endoscopy, Clin Gastroenterol Hepatol, 6, 30, 10.1016/j.cgh.2007.10.006 · doi:10.1016/j.cgh.2007.10.006
- Cooper, 2006, Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence, Aliment Pharmacol Ther, 23, 727, 10.1111/j.1365-2036.2006.02825.x · DOI
- Campos, 2001, Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease, Arch Surg, 136, 1267, 10.1001/archsurg.136.11.1267 · doi:10.1001/archsurg.136.11.1267
- Falk, 2005, Barrett's esophagus in women: demographic features and progression to high-grade dysplasia and cancer, Clin Gastroenterol Hepatol, 3, 1089, 10.1016/S1542-3565(05)00606-3 · doi:10.1016/s1542-3565(05)00606-3
- Corley, 2009, Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994–2006, Gut, 58, 182, 10.1136/gut.2008.163360 · doi:10.1136/gut.2008.163360
- Eloubeidi, 2001, Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans, J Clin Gastroenterol, 33, 306, 10.1097/00004836-200110000-00010 · doi:10.1097/00004836-200110000-00010
- Srinivasan, 2004, Profile of GERD in the adult population of a northeast urban community, J Clin Gastroenterol, 38, 651, 10.1097/01.mcg.0000135364.12794.e5 · doi:10.1097/01.mcg.0000135364.12794.e5
- Spechler, 2002, Racial differences in the frequency of symptoms and complications of gastro-oesophageal reflux disease, Aliment Pharmacol Ther, 16, 1795, 10.1046/j.1365-2036.2002.01351.x · doi:10.1046/j.1365-2036.2002.01351.x
- Eisen, 1997, The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus [see comments], Am J Gastroenterol, 92, 27
- Lieberman, 1997, Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy, Am J Gastroenterol, 92, 1293
- Kamat, 2009, Exploring the association between elevated body mass index and Barrett's esophagus: a systematic review and meta-analysis, Ann Thorac Surg, 87, 655, 10.1016/j.athoracsur.2008.08.003 · doi:10.1016/j.athoracsur.2008.08.003
- Akiyama, 2008, Alcohol consumption is associated with an increased risk of erosive esophagitis and Barrett's epithelium in Japanese men, BMC Gastroenterol, 8, 58, 10.1186/1471-230X-8-58 · doi:10.1186/1471-230x-8-58
- Kubo, 2009, Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus, Gastroenterology, 136, 806, 10.1053/j.gastro.2008.11.042 · doi:10.1053/j.gastro.2008.11.042
- Kubo, 2009, Cigarette smoking and the risk of Barrett's esophagus, Cancer Causes Control, 20, 303
- Rubenstein, 2008, Influence of malpractice history on the practice of screening and surveillance for Barrett's esophagus, Am J Gastroenterol, 103, 842, 10.1111/j.1572-0241.2007.01689.x · doi:10.1111/j.1572-0241.2007.01689.x
- Playford, 2006, New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus, Gut, 55, 442, 10.1136/gut.2005.083600 · doi:10.1136/gut.2005.083600
- Schnell, 2001, Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia, Gastroenterology, 120, 1607, 10.1053/gast.2001.25065 · doi:10.1053/gast.2001.25065
- Eloubeidi, 1999, Does this patient have Barrett's esophagus?, Am J Gastroenterol, 94, 937, 10.1111/j.1572-0241.1999.990_m.x · doi:10.1111/j.1572-0241.1999.990_m.x
- Chatelain, 2003, High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins, Virchows Arch, 442, 18, 10.1007/s00428-002-0674-1 · doi:10.1007/s00428-002-0674-1
- Shaheen, 2001, Screening strategies in gastroesophageal reflux disease: early identification of esophageal carcinoma, Adv Intern Med, 47, 137
- Spechler, 2005, Dysplasia in Barrett's esophagus: limitations of current management strategies, Am J Gastroenterol, 100, 927, 10.1111/j.1572-0241.2005.41201.x · doi:10.1111/j.1572-0241.2005.41201.x
- Collard, 2002, High-grade dysplasia in Barrett's esophagus, Chest Surg Clin North Am, 12, 77, 10.1016/S1052-3359(03)00067-X · doi:10.1016/s1052-3359(03)00067-x
- Konda, 2008, Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated?, Clin Gastroenterol Hepatol, 6, 159, 10.1016/j.cgh.2007.09.013 · doi:10.1016/j.cgh.2007.09.013
- Rastogi, 2008, Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis, Gastrointest Endosc, 67, 394, 10.1016/j.gie.2007.07.019 · doi:10.1016/j.gie.2007.07.019
- Schnell, 2001, Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia, Gastroenterology, 120, 1607, 10.1053/gast.2001.25065 · doi:10.1053/gast.2001.25065
- Reid, 2000, Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets, Am J Gastroenterol, 95, 1669
- Sharma, 2004, Low-grade dysplasia in Barrett's esophagus, Gastroenterology, 127, 1233, 10.1053/j.gastro.2004.07.061 · doi:10.1053/j.gastro.2004.07.061
- Srivastava, 2007, Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus, Am J Gastroenterol, 102, 483, 10.1111/j.1572-0241.2007.01073.x · doi:10.1111/j.1572-0241.2007.01073.x
- Fitzgerald, 2001, Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus, Dig Dis Sci, 46, 1892, 10.1023/A:1010678913481 · doi:10.1023/a:1010678913481
- Curvers, 2008, Quality of Barrett's surveillance in The Netherlands: a standardized review of endoscopy and pathology reports, Eur J Gastroenterol Hepatol, 20, 601, 10.1097/MEG.0b013e3282f8295d · doi:10.1097/meg.0b013e3282f8295d
- Fountoulakis, 2004, Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer, Br J Surg, 91, 997, 10.1002/bjs.4591 · doi:10.1002/bjs.4591
- Kearney, 2003, A case-control study of endoscopy and mortality from adenocarcinoma of the esophagus or gastric cardia in persons with GERD, Gastrointest Endosc, 57, 823, 10.1016/S0016-5107(03)70015-7 · doi:10.1016/s0016-5107(03)70015-7
- Downs-Kelly, 2008, Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies, Am J Gastroenterol, 103, 2333, 10.1111/j.1572-0241.2008.02020.x · doi:10.1111/j.1572-0241.2008.02020.x
- van Dekken, 2008, Immunohistochemical evaluation of a panel of tumor cell markers during malignant progression in Barrett esophagus, Am J Clin Pathol, 130, 745, 10.1309/AJCPO31THGVEUIDH · doi:10.1309/ajcpo31thgveuidh
- Shi, 2008, p16, cyclin D1, Ki-67, and AMACR as markers for dysplasia in Barrett esophagus, Appl Immunohistochem Mol Morphol, 16, 447, 10.1097/PAI.0b013e318168598b · doi:10.1097/pai.0b013e318168598b
- Reid, 2000, Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets, Am J Gastroenterol, 95, 1669
- Rabinovitch, 2001, Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables, Am J Gastroenterol, 96, 3071, 10.1111/j.1572-0241.2001.05261.x · doi:10.1111/j.1572-0241.2001.05261.x
- Kerkhof, 2008, Aneuploidy and high expression of p53 and Ki67 is associated with neoplastic progression in Barrett esophagus, Cancer Biomark, 4, 1, 10.3233/CBM-2008-4101 · doi:10.3233/cbm-2008-4101
- Huang, 2008, Comparison of DNA histograms by standard flow cytometry and image cytometry on sections in Barrett's adenocarcinoma, BMC Clin Pathol, 8, 5, 10.1186/1472-6890-8-5 · doi:10.1186/1472-6890-8-5
- Rygiel, 2008, Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett's esophagus brush cytology specimens, Genes Chromosomes Cancer, 47, 396, 10.1002/gcc.20543 · doi:10.1002/gcc.20543
- Cestari, 2007, Fluorescence in situ hybridization to evaluate dysplasia in Barrett's esophagus: a pilot study, Cancer Lett, 251, 278, 10.1016/j.canlet.2006.11.033 · doi:10.1016/j.canlet.2006.11.033
- Rygiel, 2007, Efficient automated assessment of genetic abnormalities detected by fluorescence in situ hybridization on brush cytology in a Barrett esophagus surveillance population, Cancer, 109, 1980, 10.1002/cncr.22643 · doi:10.1002/cncr.22643
- Nelson, 2000, High resolution and high-magnification endoscopy: September 2000, Gastrointest Endosc, 52, 864, 10.1016/S0016-5107(00)70225-2 · doi:10.1016/s0016-5107(00)70225-2
- Sharma, 2005, Magnification endoscopy, Gastrointest Endosc, 61, 435, 10.1016/S0016-5107(04)02736-1 · doi:10.1016/s0016-5107(04)02736-1
- Yao, 2006, Magnification endoscopy outlines the microvascular architecture and extent of Barrett's intramucosal carcinoma prior to endoscopic resection, Gastrointest Endosc, 63, 1064, 10.1016/j.gie.2006.01.004 · doi:10.1016/j.gie.2006.01.004
- Wani, 2007, Endoscopic surface imaging of Barrett's esophagus: an optimistic view, Gastroenterology, 133, 11, 10.1053/j.gastro.2007.05.062 · doi:10.1053/j.gastro.2007.05.062
- Kara, 2005, A randomized cross-over study comparing light-induced fluorescence endoscopy with standard video endoscopy for the detection of early neoplasia in Barrett's esophagus, Gastrointest Endosc, 61, 671, 10.1016/S0016-5107(04)02777-4 · doi:10.1016/s0016-5107(04)02777-4
- Kara, 2005, High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett's esophagus: a prospective randomized crossover study, Endoscopy, 37, 929, 10.1055/s-2005-870433 · doi:10.1055/s-2005-870433
- Canto, 2001, Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study, Endoscopy, 33, 391, 10.1055/s-2001-14427 · doi:10.1055/s-2001-14427
- Sharma, 2001, Methylene blue chromoendoscopy for detection of short-segment Barrett's esophagus, Gastrointest Endosc, 54, 289, 10.1067/mge.2001.115728 · doi:10.1067/mge.2001.115728
- Breyer, 2003, Does methylene blue detect intestinal metaplasia in Barrett's esophagus?, Gastrointest Endosc, 57, 505, 10.1067/mge.2003.137 · doi:10.1067/mge.2003.137
- Horwhat, 2008, A randomized comparison of methylene blue-directed biopsy versus conventional four-quadrant biopsy for the detection of intestinal metaplasia and dysplasia in patients with long-segment Barrett's esophagus, Am J Gastroenterol, 103, 546, 10.1111/j.1572-0241.2007.01601.x · doi:10.1111/j.1572-0241.2007.01601.x
- Lim, 2006, Randomized crossover study that used methylene blue or random 4-quadrant biopsy for the diagnosis of dysplasia in Barrett's esophagus, Gastrointest Endosc, 64, 195, 10.1016/j.gie.2005.07.025 · doi:10.1016/j.gie.2005.07.025
- Meining, 2004, Inter- and intra-observer variability of magnification chromoendoscopy for detecting specialized intestinal metaplasia at the gastroesophageal junction, Endoscopy, 36, 160, 10.1055/s-2004-814183 · doi:10.1055/s-2004-814183
- Sharma, 2003, Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus, Gut, 52, 24, 10.1136/gut.52.1.24 · doi:10.1136/gut.52.1.24
- Guelrud, 1998, Acetic acid improves identification of remnant islands of Barrett's epithelium after endoscopic therapy, Gastrointest Endosc, 47, 512, 10.1016/S0016-5107(98)70253-6 · doi:10.1016/s0016-5107(98)70253-6
- Ngamruengphong, 2009, Diagnostic yield of methylene blue chromoendoscopy for detecting specialized intestinal metaplasia and dysplasia in Barrett's esophagus: a meta-analysis, Gastrointest Endosc, 69, 1021, 10.1016/j.gie.2008.06.056 · doi:10.1016/j.gie.2008.06.056
- Guelrud, 2001, Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus, Gastrointest Endosc, 53, 559, 10.1067/mge.2001.114059 · doi:10.1067/mge.2001.114059
- Pohl, 2007, Comparison of computed virtual chromoendoscopy and conventional chromoendoscopy with acetic acid for detection of neoplasia in Barrett's esophagus, Endoscopy, 39, 594, 10.1055/s-2007-966649 · doi:10.1055/s-2007-966649
- Kara, 2006, Detection and classification of the mucosal and vascular patterns (mucosal morphology) in Barrett's esophagus by using narrow band imaging, Gastrointest Endosc, 64, 155, 10.1016/j.gie.2005.11.049 · doi:10.1016/j.gie.2005.11.049
- Curvers, 2008, Chromoendoscopy and narrow-band imaging compared with high-resolution magnification endoscopy in Barrett's esophagus, Gastroenterology, 134, 670, 10.1053/j.gastro.2008.01.003 · doi:10.1053/j.gastro.2008.01.003
- Wolfsen, 2008, Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's esophagus, Gastroenterology, 135, 24, 10.1053/j.gastro.2008.03.019 · doi:10.1053/j.gastro.2008.03.019
- Sharma, 2009, Detection of metaplasia and neoplasia in patients with Barrett's esophagus using high-definition white light endoscopy versus narrow band imaging: a prospective, multi-center, randomized, crossover trial, Gastrointest Endosc, 69, AB135, 10.1016/j.gie.2009.03.181 · doi:10.1016/j.gie.2009.03.181
- Kara, 2005, Endoscopic video autofluorescence imaging may improve the detection of early neoplasia in patients with Barrett's esophagus, Gastrointest Endosc, 61, 679, 10.1016/S0016-5107(04)02577-5 · doi:10.1016/s0016-5107(04)02577-5
- Kara, 2006, Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett's esophagus, Gastrointest Endosc, 64, 176, 10.1016/j.gie.2005.11.050 · doi:10.1016/j.gie.2005.11.050
- Curvers, 2008, Endoscopic tri-modal imaging for detection of early neoplasia in Barrett's oesophagus; a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system, Gut, 57, 167, 10.1136/gut.2007.134213 · doi:10.1136/gut.2007.134213
- Meining, 2007, In vivo histopathology for detection of gastrointestinal neoplasia with a portable, confocal miniprobe: an examiner blinded analysis, Clin Gastroenterol Hepatol, 5, 1261, 10.1016/j.cgh.2007.05.019 · doi:10.1016/j.cgh.2007.05.019
- Kumagai, 2004, Magnifying chromoendoscopy of the esophagus: in-vivo pathological diagnosis using an endocytoscopy system, Endoscopy, 36, 590, 10.1055/s-2004-814533 · doi:10.1055/s-2004-814533
- Pohl, 2007, Evaluation of endocytoscopy in the surveillance of patients with Barrett's esophagus, Endoscopy, 39, 492, 10.1055/s-2007-966340 · doi:10.1055/s-2007-966340
- Georgakoudi, 2001, Fluorescence, reflectance and light scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus, Gastroenterology, 120, 1620, 10.1053/gast.2001.24842 · doi:10.1053/gast.2001.24842
- Kobayashi, 1998, High-resolution cross-sectional imaging of the gastrointestinal tract using optical coherence tomography: preliminary results, Gastrointest Endosc, 47, 515, 10.1016/S0016-5107(98)70254-8 · doi:10.1016/s0016-5107(98)70254-8
- Bouma, 2000, High-resolution imaging of the human esophagus and stomach in vivo using optical coherence tomography, Gastrointest Endosc, 51, 467, 10.1016/S0016-5107(00)70449-4 · doi:10.1016/s0016-5107(00)70449-4
- Poneros, 2001, Diagnosis of specialized metaplasia by optical coherence tomography, Gastroenterology, 120, 7, 10.1053/gast.2001.20911 · doi:10.1053/gast.2001.20911
- Evans, 2006, Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus, Clin Gastroenterol Hepatol, 4, 38, 10.1016/S1542-3565(05)00746-9 · doi:10.1016/s1542-3565(05)00746-9
- Qi, 2006, Computer-aided diagnosis of dysplasia in Barrett's esophagus using endoscopic optical coherence tomography, J Biomed Opt, 11, 044010, 10.1117/1.2337314 · DOI
- Cooper, 2006, Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence, Aliment Pharmacol Ther, 23, 727, 10.1111/j.1365-2036.2006.02825.x · DOI
- Peters, 2000, Effect of elimination of acid reflux on epithelial cell proliferative activity of Barrett esophagus, Scand J Gastroenterol, 35, 1238, 10.1080/003655200453557 · doi:10.1080/003655200453557
- Kim, 2007, Sulindac prevents esophageal adenocarcinomas induced by gastroduodenal reflux in rats, Yonsei Med J, 48, 1020, 10.3349/ymj.2007.48.6.1020 · doi:10.3349/ymj.2007.48.6.1020
- Kaur, 2002, Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus, Gastroenterology, 123, 60, 10.1053/gast.2002.34244 · doi:10.1053/gast.2002.34244
- Yeh, 2003, Efficacy of esomeprazole in controlling reflux symptoms, intraesophageal, and intragastric pH in patients with Barrett's esophagus, Dis Esophagus, 16, 193, 10.1046/j.1442-2050.2003.00327.x · doi:10.1046/j.1442-2050.2003.00327.x
- Gerson, 2004, Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors, Aliment Pharmacol Ther, 20, 637, 10.1111/j.1365-2036.2004.02127.x · doi:10.1111/j.1365-2036.2004.02127.x
- McCallum, 1991, Role of anti-reflux surgery against dysplasia in Barrett's esophagus (abstr), Gastroenterology, 100, A121
- Katz, 1998, The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus, Am J Gastroenterol, 93, 536, 10.1111/j.1572-0241.1998.161_b.x · DOI
- Oberg, 2005, Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma, Ann Surg, 242, 49, 10.1097/01.sla.0000167864.46462.9f · doi:10.1097/01.sla.0000167864.46462.9f
- Corey, 2003, Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus?, Am J Gastroenterol, 98, 2390, 10.1111/j.1572-0241.2003.08702.x · doi:10.1111/j.1572-0241.2003.08702.x
- Feith, 2003, Pattern of lymphatic spread of Barrett's cancer, World J Surg, 27, 1052, 10.1007/s00268-003-7060-2 · doi:10.1007/s00268-003-7060-2
- Peyre, 2007, Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and Barrett with high-grade dysplasia, Ann Surg, 246, 665, 10.1097/SLA.0b013e318155a7a1 · doi:10.1097/sla.0b013e318155a7a1
- Falk, 1994, Endosonography in the evaluation of patients with Barrett's esophagus and high-grade dysplasia, Gastrointest Endosc, 40, 207, 10.1016/S0016-5107(94)70168-7 · doi:10.1016/s0016-5107(94)70168-7
- Waxman, 2006, High frequency probe ultrasonography has limited accuracy for detecting invasive adenocarcinoma in patients with Barrett's esophagus and high grade dysplasia or intramucosal carcinoma: a case series, Am J Gastroenterol, 101, 1773, 10.1111/j.1572-0241.2006.00617.x · doi:10.1111/j.1572-0241.2006.00617.x
- Larghi, 2005, EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus, Gastrointest Endosc, 62, 16, 10.1016/S0016-5107(05)00319-6 · doi:10.1016/s0016-5107(05)00319-6
- Prasad, 2007, Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus, Am J Gastroenterol, 102, 2380, 10.1111/j.1572-0241.2007.01419.x · doi:10.1111/j.1572-0241.2007.01419.x
- Giovannini, 2004, Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer, Endoscopy, 36, 782, 10.1055/s-2004-825813 · doi:10.1055/s-2004-825813
- Seewald, 2003, Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma, Gastrointest Endosc, 57, 854, 10.1016/S0016-5107(03)70020-0 · doi:10.1016/s0016-5107(03)70020-0
- Conio, 2005, Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: an Italian experience, World J Gastroenterol, 11, 6650, 10.3748/wjg.v11.i42.6650 · doi:10.3748/wjg.v11.i42.6650
- Soehendra, 2006, Use of modified multiband ligator facilitates circumferential EMR in Barrett's esophagus (with video), Gastrointest Endosc, 63, 847, 10.1016/j.gie.2005.06.052 · doi:10.1016/j.gie.2005.06.052
- Larghi, 2007, Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma, Endoscopy, 39, 1086, 10.1055/s-2007-966788 · doi:10.1055/s-2007-966788
- Lopes, 2007, Circumferential endoscopic resection of Barrett's esophagus with high-grade dysplasia or early adenocarcinoma, Surg Endosc, 21, 820, 10.1007/s00464-006-9187-3 · doi:10.1007/s00464-006-9187-3
- Montes, 1999, Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus, Gastrointest Endosc, 50, 173, 10.1016/S0016-5107(99)70220-8 · doi:10.1016/s0016-5107(99)70220-8
- Sampliner, 2001, Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study, Gastrointest Endosc, 53, 554, 10.1067/mge.2001.114418 · doi:10.1067/mge.2001.114418
- Sharma, 2006, A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results, Gut, 55, 1233, 10.1136/gut.2005.086777 · doi:10.1136/gut.2005.086777
- Dulai, 2005, Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus, Gastrointest Endosc, 61, 232, 10.1016/S0016-5107(04)02576-3 · doi:10.1016/s0016-5107(04)02576-3
- Mork, 2007, High recurrence rate of Barrett's epithelium during long-term follow-up after argon plasma coagulation, Scand J Gastroenterol, 42, 23, 10.1080/00365520600825125 · doi:10.1080/00365520600825125
- Kelty, 2004, Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation, Aliment Pharmacol Ther, 20, 1289, 10.1111/j.1365-2036.2004.02277.x · doi:10.1111/j.1365-2036.2004.02277.x
- Sharma, 2007, Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients, Gastrointest Endosc, 65, 185, 10.1016/j.gie.2006.09.033 · doi:10.1016/j.gie.2006.09.033
- Fleischer, 2008, Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up, Gastrointest Endosc, 68, 867, 10.1016/j.gie.2008.03.008 · doi:10.1016/j.gie.2008.03.008
- Manner, 2006, Ablation of nonneoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation, Am J Gastroenterol, 101, 1762, 10.1111/j.1572-0241.2006.00709.x · doi:10.1111/j.1572-0241.2006.00709.x
- Familiari, 2003, Endoscopic treatment of Barrett's epithelium with argon plasma coagulation, Minerva Gastroenterol Dietol, 49, 63
- Ragunath, 2005, Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness, Scand J Gastroenterol, 40, 750, 10.1080/00365520510015737 · doi:10.1080/00365520510015737
- Sharma, 2009, Circumferential and focal ablation of Barrett's esophagus containing dysplasia, Am J Gastroenterol, 104, 310, 10.1038/ajg.2008.142 · doi:10.1038/ajg.2008.142
- Peters, 2006, Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study, Am J Gastroenterol, 101, 1449, 10.1111/j.1572-0241.2006.00635.x · DOI · Paper page
- Ganz, 2008, Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia a U.S. multicenter registry, Gastrointest Endosc, 68, 35, 10.1016/j.gie.2007.12.015 · doi:10.1016/j.gie.2007.12.015
- Johnston, 2005, Cryoablation of Barrett's esophagus: a pilot study, Gastrointest Endosc, 62, 842, 10.1016/j.gie.2005.05.008 · doi:10.1016/j.gie.2005.05.008
- Dumot, 2009, An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients, Gastrointest Endosc, 70, 635, 10.1016/j.gie.2009.02.006 · doi:10.1016/j.gie.2009.02.006
- Attwood, 2003, Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus, Clin Gastroenterol Hepatol, 1, 258, 10.1016/S1542-3565(03)00128-9 · doi:10.1016/s1542-3565(03)00128-9
- Bronner, 2009, Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia, Gastroenterology, 136, 56, 10.1053/j.gastro.2008.10.012 · doi:10.1053/j.gastro.2008.10.012
- Van Lanschot, 2001, Hospital volume and hospital mortality for esophagectomy, Cancer, 91, 1574, 10.1002/1097-0142(20010415)91:8<1574::AID-CNCR1168>3.0.CO;2-2 · doi:10.1002/1097-0142(20010415)91:8<1574::aid-cncr1168>3.0.co;2-2
- Prasad, 2009, Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus, Gastroenterology, 137, 815, 10.1053/j.gastro.2009.05.059 · DOI
- Wang, 2009, Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience, Gastrointest Endosc, 69, 777, 10.1016/j.gie.2008.05.013 · doi:10.1016/j.gie.2008.05.013
- Altorki, 2008, Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment, Ann Surg, 247, 434, 10.1097/SLA.0b013e318163a2ff · doi:10.1097/sla.0b013e318163a2ff
- Munítiz, 2007, [Surgical treatment of high-grade dysplasia in Barrett's esophagus, ] Cir Esp, 82, 214, 10.1016/S0009-739X(07)71709-8 · doi:10.1016/s0009-739x(07)71709-8
- Williams, 2007, Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome, J Gastrointest Surg, 11, 1589, 10.1007/s11605-007-0330-9 · doi:10.1007/s11605-007-0330-9
- Peyre, 2007, Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and Barrett with high-grade dysplasia, Ann Surg, 246, 665, 10.1097/SLA.0b013e318155a7a1 · doi:10.1097/sla.0b013e318155a7a1
- Chang, 2006, Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett's esophagus, J Gastrointest Surg, 10, 341, 10.1016/j.gassur.2005.12.007 · doi:10.1016/j.gassur.2005.12.007
- Sujendran, 2005, Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus, Eur J Cardiothorac Surg, 28, 763, 10.1016/j.ejcts.2005.08.018 · doi:10.1016/j.ejcts.2005.08.018
- Reed, 2005, Surgical treatment of esophageal high-grade dysplasia, Ann Thorac Surg, 79, 1110, 10.1016/j.athoracsur.2004.09.006 · doi:10.1016/j.athoracsur.2004.09.006
- Heitmiller, 2003, Prophylactic esophagectomy in Barrett esophagus with high-grade dysplasia, Langenbecks Arch Surg, 388, 83, 10.1007/s00423-002-0343-5 · doi:10.1007/s00423-002-0343-5
- Thomson, 2003, Oesophagectomy for early adenocarcinoma and dysplasia arising in Barrett's oesophagus, ANZ J Surg, 73, 121, 10.1046/j.1445-2197.2003.02646.x · doi:10.1046/j.1445-2197.2003.02646.x
- Tseng, 2003, Barrett's esophagus with high grade dysplasia: surgical results and long-term outcome—an update, J Gastrointest Surg, 7, 164, 10.1016/S1091-255X(02)00153-1 · doi:10.1016/s1091-255x(02)00153-1
- Perry, 2002, Minimally invasive esophagectomy in the elderly, JSLS, 6, 299
- Scott Bolton, 2001, Esophagectomy for adenocarcinoma in patients 45 years of age and younger, J Gastrointest Surg, 5, 620, 10.1016/S1091-255X(01)80104-9 · doi:10.1016/s1091-255x(01)80104-9
- Zaninotto, 2000, Oesophageal resection for high-grade dysplasia in Barrett's oesophagus, Br J Surg, 87, 1102, 10.1046/j.1365-2168.2000.01470.x · doi:10.1046/j.1365-2168.2000.01470.x
- Nguyen, 2000, Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia, Surgery, 127, 284, 10.1067/msy.2000.103489 · doi:10.1067/msy.2000.103489
- Catrambone, 1999, Complications of Barrett's esophagus: indications for esophageal resection with special reference to high-grade dysplasia, Minerva Chir, 54, 657
- Patti, 1999, Barrett's esophagus: a surgical disease, J Gastrointest Surg, 3, 397, 10.1016/S1091-255X(99)80056-0 · doi:10.1016/s1091-255x(99)80056-0
- Luketich, 1998, Minimally invasive approach to esophagectomy, JSLS, 2, 243
- Lerut, 1994, Surgical treatment of Barrett's carcinoma, J Thorac Cardiovasc Surg, 107, 1059, 10.1016/S0022-5223(94)70381-7 · doi:10.1016/s0022-5223(94)70381-7
- Parameswaran, 2008, The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: a systematic review, Ann Surg Oncol, 15, 2372, 10.1245/s10434-008-0042-8 · DOI
- Dresner, 2003, Human model of duodenogastro-oesophageal reflux in the development of Barrett's metaplasia, Br J Surg, 90, 1120, 10.1002/bjs.4169 · doi:10.1002/bjs.4169
- Franchimont, 2003, Newly developed Barrett's esophagus after subtotal esophagectomy, Endoscopy, 35, 850, 10.1055/s-2003-42623 · doi:10.1055/s-2003-42623
- da Rocha, 2008, Barrett's esophagus (BE) and carcinoma in the esophageal stump (ES) after esophagectomy with gastric pull-up in achalasia patients: a study based on 10 years follow-up, Ann Surg Oncol, 15, 2903, 10.1245/s10434-008-0057-1 · doi:10.1245/s10434-008-0057-1
- Gutschow, 2008, Adenocarcinoma developing in de novo Barrett's mucosa in the remnant esophagus after esophagectomy: clinical and molecular assessment, Dis Esophagus, 21, E6, 10.1111/j.1442-2050.2007.00784.x · doi:10.1111/j.1442-2050.2007.00784.x
- Wolfsen, 2004, Recurrent Barrett's esophagus and adenocarcinoma after esophagectomy, BMC Gastroenterol, 4, 18, 10.1186/1471-230X-4-18 · doi:10.1186/1471-230x-4-18
Cited by
Fitzgerald, R. C., di Pietro, M., Ragunath, K., Ang, Y., Kang, J.-Y., Watson, P., Trudgill, N., Patel, P., Kaye, P. V., Sanders, S., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305372 · Cited by 1,346
Rustgi, A. K., & El-Serag, H. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1314530 · Cited by 1,243
(2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.030 · Cited by 1,009
Freedberg, D. E., Kim, L. S., & Yang, Y.-X. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.031 · Cited by 891
The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis
Desai, T. K., Krishnan, K., Samala, N., Singh, J., Cluley, J., Perla, S., & Howden, C. W. (2012) · Gut · doi:10.1136/gutjnl-2011-300730 · Cited by 609
Trends in esophageal adenocarcinoma incidence and mortality
Hur, C., Miller, M., Kong, C. Y., Dowling, E. C., Nattinger, K. J., Dunn, M., & Feuer, E. J. (2013) · Cancer · doi:10.1002/cncr.27834 · Cited by 507
Addressing overdiagnosis and overtreatment in cancer: a prescription for change
Esserman, L. J., Thompson, I. M., Reid, B., Nelson, P., Ransohoff, D. F., Welch, H. G., Hwang, S., Berry, D. A., Kinzler, K. W., Black, W. C., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70598-9 · Cited by 501
Pech, O., May, A., Manner, H., Behrens, A., Pohl, J., Weferling, M., Hartmann, U., Manner, N., Huijsmans, J., Gossner, L., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.006 · Cited by 499
Spechler, S. J., & Souza, R. F. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1314704 · Cited by 495
Self-citationfor the SIF-AIGO-FIMMG Group, Scarpignato, C., on behalf of the Italian Society of Pharmacology, T. I. A. O. H. G., Gatta, L., Zullo, A., & Blandizzi, C. (2016) · BMC Medicine · doi:10.1186/s12916-016-0718-z · Cited by 469
Salminen, P., Grönroos, S., Helmiö, M., Hurme, S., Juuti, A., Juusela, R., Peromaa-Haavisto, P., Leivonen, M., Nuutila, P., & Ovaska, J. (2022) · JAMA Surgery · doi:10.1001/jamasurg.2022.2229 · Cited by 456
ASGE guideline on screening and surveillance of Barrett’s esophagus
Qumseya, B., Sultan, S., Bain, P., Jamil, L., Jacobson, B., Anandasabapathy, S., Agrawal, D., Buxbaum, J. L., Fishman, D. S., Gurudu, S. R., et al. (2019) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2019.05.012 · Cited by 437
Genco, A., Soricelli, E., Casella, G., Maselli, R., Castagneto-Gissey, L., Di Lorenzo, N., & Basso, N. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.11.029 · Cited by 424
Bennett, C., Vakil, N., Bergman, J., Harrison, R., Odze, R., Vieth, M., Sanders, S., Gay, L., Pech, O., Longcroft–Wheaton, G., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.032 · Cited by 375
Self-citationThe role of endoscopy in Barrett's esophagus and other premalignant conditions of the esophagus
Evans, J. A., Early, D. S., Fukami, N., Ben-Menachem, T., Chandrasekhara, V., Chathadi, K. V., Decker, G. A., Fanelli, R. D., Fisher, D. A., Foley, K. Q., et al. (2012) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2012.08.004 · Cited by 354
de Groof, A. J., Struyvenberg, M. R., van der Putten, J., van der Sommen, F., Fockens, K. N., Curvers, W. L., Zinger, S., Pouw, R. E., Coron, E., Baldaque-Silva, F., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.030 · Cited by 340
Ross-Innes, C. S., Debiram-Beecham, I., O'Donovan, M., Walker, E., Varghese, S., Lao-Sirieix, P., Lovat, L., Griffin, M., Ragunath, K., Haidry, R., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001780 · Cited by 304
Singh, S., Garg, S. K., Singh, P. P., Iyer, P. G., & El-Serag, H. B. (2014) · Gut · doi:10.1136/gutjnl-2013-305997 · Cited by 298
Orman, E. S., Li, N., & Shaheen, N. J. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.03.039 · Cited by 296
Self-citationDuits, L. C., Phoa, K. N., Curvers, W. L., ten Kate, F. J. W., Meijer, G. A., Seldenrijk, C. A., Offerhaus, G. J., Visser, M., Meijer, S. L., Krishnadath, K. K., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307278 · Cited by 286
Barrett Esophagus and Risk of Esophageal Cancer: A Clinical Review
Spechler, S. J. (2013) · JAMA · doi:10.1001/jama.2013.226450 · Cited by 284
Self-citationPhoa, K. N., Pouw, R. E., Bisschops, R., Pech, O., Ragunath, K., Weusten, B. L. A. M., Schumacher, B., Rembacken, B., Meining, A., Messmann, H., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309298 · Cited by 265
Fitzgerald, R. C., di Pietro, M., O'Donovan, M., Maroni, R., Muldrew, B., Debiram-Beecham, I., Gehrung, M., Offman, J., Tripathi, M., Smith, S. G., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31099-0 · Cited by 261
Yang, L., Francois, F., & Pei, Z. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0934 · Cited by 192
Barrett's esophagus is associated with a distinct oral microbiome
Snider, E. J., Compres, G., Freedberg, D. E., Giddins, M. J., Khiabanian, H., Lightdale, C. J., Nobel, Y. R., Toussaint, N. C., Uhlemann, A.-C., & Abrams, J. A. (2018) · Clinical and Translational Gastroenterology · doi:10.1038/s41424-018-0005-8 · Cited by 72
Metadata
- Authors
- Spechler, S. J., Sharma, P., Souza, R. F., Inadomi, J. M., & Shaheen, N. J.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 140
- Issue
- 3
- Pages
- e18-e52
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2024455739
- Cited by
- 1,060
- References
- 164
- FWCI
- 95.53
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.